Lamotrix

Lamotrigine, the active ingredient in Lamotrix, is an anticonvulsant presented as an oral dosage form for oral administration. It is indicated for the treatment of various seizure types in epilepsy and is employed as a maintenance therapy to stabilize mood in adults with bipolar disorder. By modulating neuronal excitability, lamotrigine helps reduce the frequency of seizures and prevents mood swings associated with bipolar illness.

GNH USA supplies Lamotrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing and reliable global distribution.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neurological and psychiatric pathways. - Epilepsy: reduces seizure frequency and severity in patients with focal and generalized seizures. - Bipolar disorder (maintenance therapy): helps prevent recurrence of depressive and manic episodes. - Partial seizures: provides control of focal onset seizures with or without secondary generalization.

Lamotrigine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash (mild)

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Aseptic meningitis - Severe skin reactions such as DRESS - Hematologic abnormalities (e.g., aplastic anemia)

When prescribing lamotrigine, clinicians should consider several safety precautions to minimize risks. - Monitor skin reactions: discontinue immediately if signs of severe rash appear. - Assess hepatic function: adjust dose in patients with liver impairment. - Avoid abrupt discontinuation: taper under medical supervision to prevent seizure recurrence. - Use caution in pregnancy: discuss potential risks and benefits with the patient. - Counsel on contraceptive use: hormonal contraceptives can lower lamotrigine levels. - Store at room temperature: keep in the original container, protect from moisture and heat.

Lamotrigine's plasma concentrations can be altered by several concomitant medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine, phenytoin, phenobarbital: significantly reduce lamotrigine levels, may diminish efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: lower lamotrigine concentrations, may require dose increase. - Serotonergic agents (e.g., SSRIs, SNRIs): potential for increased risk of serotonin syndrome. - Antifungal agents (e.g., fluconazole): may modestly raise lamotrigine levels.